Nanosphere Health Sciences (FRA:2CG) Cyclically Adjusted Book per Share: €0.00 (As of Dec. 2025)


What is Nanosphere Health Sciences Cyclically Adjusted Book per Share?

Nanosphere Health Sciences FRA:2CG Cyclically Adjusted Book per Share is €0.00 as of Dec. 2025.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Nanosphere Health Sciences's adjusted book value per share for the three months ended in Dec. 2025 was €-0.112. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.00 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Nanosphere Health Sciences's average Cyclically Adjusted Book Growth Rate was 66.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -74.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Nanosphere Health Sciences was -41.00% per year. The lowest was -87.40% per year. And the median was -52.90% per year.

As of today (2026-07-05), Nanosphere Health Sciences's current stock price is €0.0075. Nanosphere Health Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was €0.00. Nanosphere Health Sciences's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Nanosphere Health Sciences was 0.37. The lowest was 0.01. And the median was 0.03.


Nanosphere Health Sciences  (FRA:2CG) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Nanosphere Health Sciences was 0.37. The lowest was 0.01. And the median was 0.03.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Nanosphere Health Sciences Cyclically Adjusted Book per Share Related Terms


Nanosphere Health Sciences Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Nanosphere Health Sciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanosphere Health Sciences Cyclically Adjusted Book per Share Chart

Nanosphere Health Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.33 1.42 -0.08 0.01 0.00

Nanosphere Health Sciences Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.00 0.00 0.00 0.00

FRA:2CG vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Nanosphere Health Sciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanosphere Health Sciences Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanosphere Health Sciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Nanosphere Health Sciences's Cyclically Adjusted PB Ratio falls into.



Nanosphere Health Sciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nanosphere Health Sciences's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=-0.112/130.3700*130.3700
=-0.112

Current CPI (Dec. 2025) = 130.3700.

Nanosphere Health Sciences Quarterly Data

Book Value per Share CPI Adj_Book
201603 -0.170 101.054 -0.219
201606 -0.228 102.002 -0.291
201609 0.670 101.765 0.858
201612 -0.261 101.449 -0.335
201703 0.584 102.634 0.742
201706 0.531 103.029 0.672
201709 0.844 103.345 1.065
201712 0.647 103.345 0.816
201803 0.466 105.004 0.579
201806 0.371 105.557 0.458
201809 0.217 105.636 0.268
201812 0.145 105.399 0.179
201903 0.267 106.979 0.325
201906 0.175 107.690 0.212
201909 0.071 107.611 0.086
201912 -0.153 107.769 -0.185
202003 -0.182 107.927 -0.220
202006 -0.197 108.401 -0.237
202009 -0.199 108.164 -0.240
202012 -0.221 108.559 -0.265
202103 -0.236 110.298 -0.279
202106 -0.254 111.720 -0.296
202109 -0.083 112.905 -0.096
202112 -0.093 113.774 -0.107
202203 -0.102 117.646 -0.113
202206 -0.112 120.806 -0.121
202209 -0.119 120.648 -0.129
202212 -0.121 120.964 -0.130
202303 -0.124 122.702 -0.132
202306 -0.131 124.203 -0.138
202309 -0.135 125.230 -0.141
202312 -0.139 125.072 -0.145
202403 -0.141 126.258 -0.146
202406 -0.147 127.522 -0.150
202409 -0.148 127.285 -0.152
202412 -0.113 127.364 -0.116
202503 -0.118 129.181 -0.119
202506 -0.117 129.892 -0.117
202509 -0.114 130.290 -0.114
202512 -0.112 130.370 -0.112

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €0.00 mean?
Nanosphere Health Sciences (FRA:2CG) has a Cyclically Adjusted Book per Share of €0.00 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Nanosphere Health Sciences and its competitors.
Is Nanosphere Health Sciences' Cyclically Adjusted Book per Share too high?
Nanosphere Health Sciences' current Cyclically Adjusted Book per Share is €0.00.
How does Nanosphere Health Sciences' Cyclically Adjusted Book per Share compare to VRTX and REGN?
Nanosphere Health Sciences' Cyclically Adjusted Book per Share of €0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Nanosphere Health Sciences and its competitors. Nanosphere Health Sciences's current Cyclically Adjusted Book per Share is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanosphere Health Sciences stock overvalued right now?
Nanosphere Health Sciences (FRA:2CG) has a current Cyclically Adjusted Book per Share of €0.00. The current Cyclically Adjusted Book per Share is €0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Nanosphere Health Sciences (FRA:2CG), the current Cyclically Adjusted Book per Share is €0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nanosphere Health Sciences Business Description

Other Exchanges NSHSF:USANSHS:Canada
Address 605 Robson Street, c/o Suite 430, Vancouver, BC, CAN, V6B 5J3
Nanosphere Health Sciences Inc is a biotechnology company focused on providing next generation delivery of biologically active compounds through licensing and joint venture arrangements. The Company has developed and is commercializing its patented NanoSphere Delivery System, a nanotechnology platform for the delivery of biological agents such as cannabinoids, supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. The NanoSphere Delivery System provides improved bioavailability, efficacy, and onset of effect over traditional delivery systems.